The Effect of Switch Treatment on Liver Fibrosis and qHBsAg Levels in Patients with Chronic Hepatitis B
Journal Title: Viral Hepatitis Journal - Year 2020, Vol 26, Issue 2
Abstract
Objectives: The aim of this study was to evaluate the relationship between clinical, biochemical, serological parameters, fibroscan imaging in terms of fibrosis and quantitative hepatitis B surface antigen (qHBsAg) levels in patients with chronic hepatitis B (CHB) infection whose treatment has been switched from LAM to TDF. Materials and Methods: The study included 19 patients with CHB and under the LAM treatment. The gender, age, comorbidity, medications, routine laboratuary, creatinine clearance, bone mineral density, transient elastography for stage of liver fibrosis and qHBsAg level were examined. Results: Ten of 19 patients were female and 9 were male. When the qHBsAg titers of the patients at 6th and 12th months were compared, there was a statistically significant decrease in qHBsAg titers of the patients after the 12th month. There was a significant decrease in liver fibrosis measurements at the 12th month of treatment change. There was a statistically significant positive correlation between qHBsAg titers and fibroscan values at baseline and 12th month. Conclusion: In this study, the replacement of LAM with TDF may prevent the resistance problem, and also the decrease in fibrosis values and/or qHBsAg levels may contribute to the prevention of HCC and cirrhosis have been showed.
Authors and Affiliations
Esra Yeşilyurt, Muhammed Kaya, Gökhan Dindar, Seyyid Bilal Açıkgöz, Fatih Güzelbulut, Hayrunnisa Sezikli, Göktuğ Şirin, Mesut Sezikli
Keywords
Related Articles
- EP ID EP688802
- DOI 10.4274/vhd.galenos.2020.2020.0008
- Views 128
- Downloads 0
Relationship between Viral Load and Hepatic Histopathology in Patients with Chronic Hepatitis B
Objectives: It is not always possible to determine a clear relationship between the DNA level of hepatitis B virus (HBV) and histology. In this study, we aimed to determine the relationship between HBV-DNA level and live...
Evaluating The Frequency of Autoantibodies in Patients with Chronic Hepatitis B
Objectives: The objective of this study is to evaluate the frequency of autoantibodies retrospectively in newly diagnosed chronic hepatitis B (CHB) patients. Materials and Methods: The study was retrospectively conducte...
Investigating Hepatitis C, D and HIV Prevalance in Cases with Positive Hepatitis B Virus Antigen in a Tertiary Hospital and Examining Anti-HDV Positive Cases
Objectives: Hepatitis B infection has a faster and more progressive course in the presence of hepatitis C virus (HCV), HDV and human immunodeficiency virus (HIV) infections. The aim of this study was to determine anti-HC...
Correlation between Hepatitis C Virus Antibodies in Saliva and Serum: A Safe Method for Epidemiological Studies
Objectives: Hepatitis C virus (HCV) infection is an increasing public health problem in developing countries. A non-invasive method is required as blood sampling is an invasive method for detecting HCV antibodies. In thi...
Evaluation of Serum CTNNβ1 and E-cadherin Levels in Hepatitis Patients
Objectives: Hepatitis B virus (HBV) infection is one of the leading causes of hepatocellular carcinoma, but the underlying molecular mechanisms are quite complex. In this study, the aim was to reveal the relationship of...